Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,031 | 41,739 | 64,886 | 121,330 | 82,906 |
| Marketable Securities | 20,161 | 72,416 | 71,648 | 26,004 | 89,709 |
| Receivables | 22,180 | 20,042 | 16,837 | 26,908 | 22,159 |
| Other current assets | 9,260 | 14,356 | 16,419 | 0 | 16,009 |
| TOTAL | $133,632 | $148,553 | $169,790 | $187,366 | $210,783 |
| Non-Current Assets | |||||
| PPE Net | 1,847 | 1,833 | 1,800 | 2,331 | 2,204 |
| Investments And Advances | N/A | N/A | N/A | N/A | 380 |
| Intangibles | 10,912 | 10,934 | 10,094 | 9,704 | 10,433 |
| Other Non-Current Assets | 399 | 3,913 | 3,614 | 3,234 | 2,869 |
| TOTAL | $13,158 | $16,680 | $15,508 | $15,269 | $15,886 |
| Total Assets | $146,790 | $165,233 | $185,298 | $202,635 | $226,669 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,993 | 14,311 | 18,812 | 3,697 | 19,098 |
| Accrued Expenses | N/A | N/A | N/A | 8,361 | N/A |
| TOTAL | $17,379 | $14,768 | $19,264 | $16,822 | $22,633 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 301 | 457 | 392 | 306 | 3,350 |
| Other Non-Current Liabilities | 0 | 0 | 225,486 | 0 | 0 |
| TOTAL | $55,348 | $56,310 | $278,777 | $51,790 | $77,556 |
| Total Liabilities | $72,727 | $71,078 | $298,041 | $68,612 | $100,189 |
| Shareholders' Equity | |||||
| Common Shares | 10,290 | 10,290 | -10,289 | 10,288 | 9,477 |
| Retained earnings | -550,802 | -529,844 | 502,536 | -474,044 | -463,886 |
| Other shareholders' equity | -3,073 | -1,404 | 8,084 | -11,781 | 88,396 |
| TOTAL | $74,063 | $94,155 | $-112,743 | $134,023 | $126,480 |
| Total Liabilities And Equity | $146,790 | $165,233 | $185,298 | $202,635 | $226,669 |